Trademark: 88251115
Word
ULTRA X
Status
Registered
Status Code
700
Status Date
Tuesday, November 1, 2022
Serial Number
88251115
Registration Number
6889874
Registration Date
Tuesday, November 1, 2022
Mark Type
4000
Filing Date
Sunday, January 6, 2019
Published for Opposition
Tuesday, July 9, 2019

Trademark Owner History
Essenlix Corporation - Original Registrant

Classifications
5 Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes
1 Assays for research purposes; Biological and chemical reagents used for non-medical purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acids, namely, DNA and RNA in a sample
44 Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services; diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing mental health and wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and wellness services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample
10 Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

Trademark Events
Nov 1, 2022
Notice Of Registration Confirmation Emailed
Nov 1, 2022
Registered-Principal Register
Sep 24, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 23, 2022
Allowed Principal Register - Sou Accepted
Sep 13, 2022
Statement Of Use Processing Complete
Sep 6, 2022
Use Amendment Filed
Sep 6, 2022
Teas Statement Of Use Received
Mar 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2022
Sou Extension 5 Granted
Mar 3, 2022
Sou Extension 5 Filed
Mar 14, 2022
Case Assigned To Intent To Use Paralegal
Mar 3, 2022
Teas Extension Received
Sep 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 3, 2021
Sou Extension 4 Granted
Sep 3, 2021
Sou Extension 4 Filed
Sep 3, 2021
Teas Extension Received
Mar 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2021
Sou Extension 3 Granted
Mar 1, 2021
Sou Extension 3 Filed
Mar 1, 2021
Teas Extension Received
Sep 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 1, 2020
Sou Extension 2 Granted
Sep 1, 2020
Sou Extension 2 Filed
Sep 1, 2020
Teas Extension Received
Feb 29, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2020
Sou Extension 1 Granted
Feb 20, 2020
Sou Extension 1 Filed
Feb 20, 2020
Teas Extension Received
Feb 20, 2020
Teas Change Of Correspondence Received
Feb 20, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 20, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 3, 2019
Noa E-Mailed - Sou Required From Applicant
Jul 9, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 9, 2019
Published For Opposition
Jun 19, 2019
Notification Of Notice Of Publication E-Mailed
May 31, 2019
Assigned To Lie
May 17, 2019
Approved For Pub - Principal Register
May 17, 2019
Examiner's Amendment Entered
May 17, 2019
Notification Of Examiners Amendment E-Mailed
May 17, 2019
Examiners Amendment E-Mailed
May 17, 2019
Examiners Amendment -Written
Mar 28, 2019
Notification Of Priority Action E-Mailed
Mar 28, 2019
Priority Action E-Mailed
Mar 28, 2019
Priority Action Written
Mar 22, 2019
Assigned To Examiner
Jan 27, 2019
New Application Office Supplied Data Entered In Tram
Jan 9, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24